9.8 USD
+0.11 (+1.14%)
Taking everything into account, MTEX scores 2 out of 10 in our fundamental rating. MTEX was compared to 35 industry peers in the Personal Care Products industry. Both the profitability and financial health of MTEX have multiple concerns. MTEX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year MTEX has reported negative net income.
In the past year MTEX has reported a negative cash flow from operations.
In multiple years MTEX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: MTEX reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -11.93%, MTEX is doing worse than 77.14% of the companies in the same industry.
The Return On Equity of MTEX (-65.56%) is worse than 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.93% | ||
| ROE | -65.56% | ||
| ROIC | N/A |
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MTEX's Profit Margin has been stable in the last couple of years.
In the last couple of years the Operating Margin of MTEX has declined.
With an excellent Gross Margin value of 75.79%, MTEX belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Gross Margin of MTEX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for MTEX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.79% |
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
2. Health
2.1 Basic Checks
MTEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MTEX has more shares outstanding
Compared to 5 years ago, MTEX has less shares outstanding
MTEX has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.69 indicates that MTEX is not in any danger for bankruptcy at the moment.
MTEX's Altman-Z score of 3.69 is fine compared to the rest of the industry. MTEX outperforms 71.43% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that MTEX is somewhat dependend on debt financing.
MTEX has a Debt to Equity ratio (0.58) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.69 |
ROIC/WACCN/A
WACC9.07%
2.3 Liquidity
MTEX has a Current Ratio of 1.11. This is a normal value and indicates that MTEX is financially healthy and should not expect problems in meeting its short term obligations.
MTEX has a Current ratio of 1.11. This is in the lower half of the industry: MTEX underperforms 77.14% of its industry peers.
A Quick Ratio of 0.49 indicates that MTEX may have some problems paying its short term obligations.
With a Quick ratio value of 0.49, MTEX is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
The earnings per share for MTEX have decreased strongly by -220.34% in the last year.
The Earnings Per Share has been decreasing by -0.73% on average over the past years.
MTEX shows a decrease in Revenue. In the last year, the revenue decreased by -7.72%.
The Revenue has been decreasing by -5.66% on average over the past years.
EPS 1Y (TTM)-220.34%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-587.36%
Revenue 1Y (TTM)-7.72%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-7.43%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
MTEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
MTEX's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.21 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
MTEX has a Yearly Dividend Yield of 8.83%, which is a nice return.
MTEX's Dividend Yield is rather good when compared to the industry average which is at 7.49. MTEX pays more dividend than 94.29% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, MTEX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.83% |
5.2 History
MTEX has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:MTEX (11/26/2025, 1:20:41 PM)
9.8
+0.11 (+1.14%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners18.95%
Inst Owner Change1.12%
Ins Owners44.9%
Ins Owner Change0%
Market Cap18.62M
Revenue(TTM)112.97M
Net Income(TTM)-3.91M
Analysts0
Price TargetN/A
Short Float %2.18%
Short Ratio0.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.83% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.16 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.12 | ||
| P/tB | 3.12 | ||
| EV/EBITDA | 21.21 |
EPS(TTM)-2.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS59.46
BVpS3.14
TBVpS3.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.93% | ||
| ROE | -65.56% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.79% | ||
| FCFM | N/A |
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
F-Score3
Asset Turnover3.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.39 | ||
| Cap/Depr | 60.38% | ||
| Cap/Sales | 0.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 3.69 |
F-Score3
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)43.45%
Cap/Depr(5y)43.17%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.34%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-587.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.72%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-7.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.57%
EBIT growth 3Y-45.85%
EBIT growth 5Y-25.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y55.05%
FCF growth 3Y-42.1%
FCF growth 5Y-11.9%
OCF growth 1Y62.38%
OCF growth 3Y-40.57%
OCF growth 5Y-14.4%
MANNATECH INC / MTEX FAQ
Can you provide the ChartMill fundamental rating for MANNATECH INC?
ChartMill assigns a fundamental rating of 2 / 10 to MTEX.
Can you provide the valuation status for MANNATECH INC?
ChartMill assigns a valuation rating of 0 / 10 to MANNATECH INC (MTEX). This can be considered as Overvalued.
What is the profitability of MTEX stock?
MANNATECH INC (MTEX) has a profitability rating of 2 / 10.
How financially healthy is MANNATECH INC?
The financial health rating of MANNATECH INC (MTEX) is 3 / 10.
How sustainable is the dividend of MANNATECH INC (MTEX) stock?
The dividend rating of MANNATECH INC (MTEX) is 5 / 10 and the dividend payout ratio is 0%.